These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9487597

  • 1. [Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
    Heidenreich A.
    Urologe A; 1997 Nov; 36(6):568. PubMed ID: 9487597
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostate cancer and bone metastases. The effect of clodronate.
    Kylmälä T.
    Ann Chir Gynaecol; 1998 Nov; 87(1):59-60. PubMed ID: 9598233
    [No Abstract] [Full Text] [Related]

  • 5. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
    Rodrigues P, Hering F, Campagnari JC.
    Prostate Cancer Prostatic Dis; 2004 Nov; 7(4):350-4. PubMed ID: 15534620
    [Abstract] [Full Text] [Related]

  • 6. Clodronate in the management of bone metastases: a clinical study of 91 patients.
    Serkies K, Jereczek-Fossa B, Badzio A, Jassem J.
    Neoplasma; 1999 Nov; 46(5):317-22. PubMed ID: 10665850
    [Abstract] [Full Text] [Related]

  • 7. [Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma].
    Vorreuther R, Klotz T, Engelking R.
    Urologe A; 1992 Mar; 31(2):63-6. PubMed ID: 1373255
    [Abstract] [Full Text] [Related]

  • 8. [Metastatic bone lesions in solid tumors and possible use of clodronate (Bonephos) in clinical oncology].
    Moiseenko VM, Blinov NN.
    Vopr Onkol; 1996 Mar; 42(2):17-30. PubMed ID: 8815629
    [No Abstract] [Full Text] [Related]

  • 9. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
    Moiseenko VM, Blinov NN, Semiglazov VV, Konstantinova MM, Trishkina EA.
    Vopr Onkol; 1998 Mar; 44(6):725-8. PubMed ID: 10087976
    [Abstract] [Full Text] [Related]

  • 10. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

  • 11. No value of oral clodronic acid in malignant osteolysis.
    Prescrire Int; 1998 Aug; 7(36):104. PubMed ID: 10342946
    [Abstract] [Full Text] [Related]

  • 12. [The effects of clodronate for the pain treatment of bone metastasis due to prostate cancer].
    Ozyuvaci E, Altan A, Demir C.
    Agri; 2005 Jan; 17(1):49-53. PubMed ID: 15791501
    [Abstract] [Full Text] [Related]

  • 13. One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
    Rovetta G, Maggiani G, Molfetta L, Monteforte P.
    Drugs Exp Clin Res; 2001 Jan; 27(2):77-81. PubMed ID: 11392057
    [Abstract] [Full Text] [Related]

  • 14. Effect of concomitant administration of clodronate and estramustine phosphate on their bioavailability in patients with metastasized prostate cancer.
    Kylmälä T, Castrén-Kortekangas P, Seppänen J, Ylitalo P, Tammela TL.
    Pharmacol Toxicol; 1996 Sep; 79(3):157-60. PubMed ID: 8884875
    [Abstract] [Full Text] [Related]

  • 15. Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
    Rovetta G, Monteforte P, Balestra V.
    Drugs Exp Clin Res; 2000 Sep; 26(1):25-30. PubMed ID: 10761534
    [Abstract] [Full Text] [Related]

  • 16. Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.
    Elomaa I, Kylmälä T, Tammela T, Viitanen J, Ottelin J, Ruutu M, Jauhiainen K, Ala-Opas M, Roos L, Seppänen J.
    Int Urol Nephrol; 1992 Sep; 24(2):159-66. PubMed ID: 1385586
    [Abstract] [Full Text] [Related]

  • 17. Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
    Kylmälä T, Taube T, Tammela TL, Risteli L, Risteli J, Elomaa I.
    Br J Cancer; 1997 Sep; 76(7):939-42. PubMed ID: 9328156
    [Abstract] [Full Text] [Related]

  • 18. [Clodronate in erosive osteoarthrosis of the hand: efficacy for pain and function recovery].
    Saviola G, Santoro L.
    G Ital Med Lav Ergon; 2000 Sep; 22(4):328-31. PubMed ID: 11284157
    [Abstract] [Full Text] [Related]

  • 19. Clodronate in the prevention and treatment of skeletal metastasis.
    Gulley J, Dahut WL.
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
    [Abstract] [Full Text] [Related]

  • 20. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain.
    Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjögren L.
    Clin Chem; 1998 Aug; 44(8 Pt 1):1621-8. PubMed ID: 9702948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.